-
1
-
-
0030344628
-
Postoperative nausea and vomiting in children
-
Baines D. 1996. Postoperative nausea and vomiting in children. Paediatr Anaesth, 6:7-14.
-
(1996)
Paediatr Anaesth
, vol.6
, pp. 7-14
-
-
Baines, D.1
-
2
-
-
0024487876
-
Area postrema: Chemoreceptor circumventricular organ of the medulla oblongat A
-
Borison HL. 1989. Area postrema: chemoreceptor circumventricular organ of the medulla oblongat A. Prog Neurobiol, 32:351-90.
-
(1989)
Prog Neurobiol
, vol.32
, pp. 351-390
-
-
Borison, H.L.1
-
3
-
-
0035129699
-
A randomized controlled trial of the antiemetic effect of three doses of ondansetron after strabismus surgery in children
-
Bowhay AR, May HA, Rudnicka AR, et al. 2001. A randomized controlled trial of the antiemetic effect of three doses of ondansetron after strabismus surgery in children. Paediatr Anaesth, 11:215-21.
-
(2001)
Paediatr Anaesth
, vol.11
, pp. 215-221
-
-
Bowhay, A.R.1
May, H.A.2
Rudnicka, A.R.3
-
4
-
-
20744449784
-
Ondansetron oral disintegrating tablets: Acceptability and efficacy in children undergoing adenotonsillectomy
-
Cohen IT, Joffe D, Hummer K. et al. 2005. Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy. Anesth Analg, 101:59-63.
-
(2005)
Anesth Analg
, vol.101
, pp. 59-63
-
-
Cohen, I.T.1
Joffe, D.2
Hummer, K.3
-
5
-
-
14644416009
-
A prospective randomized trial of the antiemetic efficacy and cost-effectivenes of intravenous and orally disintegrating tablet of ondansetron in children with cancer
-
Corapcioglu F, Sarper N. 2005. A prospective randomized trial of the antiemetic efficacy and cost-effectivenes of intravenous and orally disintegrating tablet of ondansetron in children with cancer. Pediatr Hematol Oncol, 22:103-14.
-
(2005)
Pediatr Hematol Oncol
, vol.22
, pp. 103-114
-
-
Corapcioglu, F.1
Sarper, N.2
-
6
-
-
0032948414
-
Comparison of an orallly disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study. Ondansetron Orally Disintegrating Tablet Emesis Study Group
-
Davidson N, Rapoport B, Erikstein B, et al. 1999. Comparison of an orallly disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: a multicenter, double-masked study. Ondansetron Orally Disintegrating Tablet Emesis Study Group. Clin Ther, 21:492-502.
-
(1999)
Clin Ther
, vol.21
, pp. 492-502
-
-
Davidson, N.1
Rapoport, B.2
Erikstein, B.3
-
7
-
-
9244228555
-
The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients
-
Eberhart LH, Geldner G, Kranke P. 2004. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg, 99:1630-7.
-
(2004)
Anesth Analg
, vol.99
, pp. 1630-1637
-
-
Eberhart, L.H.1
Geldner, G.2
Kranke, P.3
-
8
-
-
0036233180
-
Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery
-
Gan TJ, Franiak R, Reeves J. 2002. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg, 94:1199-200.
-
(2002)
Anesth Analg
, vol.94
, pp. 1199-1200
-
-
Gan, T.J.1
Franiak, R.2
Reeves, J.3
-
9
-
-
27444444688
-
The efficacy of postoperative ondansetron (Zofran) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery
-
Hartsell T, Long D, Kirsch JR. 2005. The efficacy of postoperative ondansetron (Zofran) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery. Anesth Analg, 101:1492-6.
-
(2005)
Anesth Analg
, vol.101
, pp. 1492-1496
-
-
Hartsell, T.1
Long, D.2
Kirsch, J.R.3
-
10
-
-
0033380913
-
Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus
-
Kathirvel S, Shende D, Madan R. 1999. Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus. Eur J Anaesthesiol. 16:761-5.
-
(1999)
Eur J Anaesthesiol
, vol.16
, pp. 761-765
-
-
Kathirvel, S.1
Shende, D.2
Madan, R.3
-
11
-
-
0034025563
-
Prevention and treatment of postoperative nausea and vomiting
-
Kovac AL. 2000. Prevention and treatment of postoperative nausea and vomiting. Drugs, 59:213-43.
-
(2000)
Drugs
, vol.59
, pp. 213-243
-
-
Kovac, A.L.1
-
12
-
-
0032707754
-
Efficacy of an ondansetron orally disintegrating tablet: A novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment
-
LeBourgeois JP, McKenna CJ, Coster B, et al. 1999. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. Clin Oncol (Royal College of Radiologists), 11:340-7.
-
(1999)
Clin Oncol (Royal College of Radiologists)
, vol.11
, pp. 340-347
-
-
LeBourgeois, J.P.1
McKenna, C.J.2
Coster, B.3
-
13
-
-
0033980048
-
Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery
-
Madan R, Perumal T, Subramaniam K, et al. 2000 Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery, Anaesth Intensive Care, 28:27-30.
-
(2000)
Anaesth Intensive Care
, vol.28
, pp. 27-30
-
-
Madan, R.1
Perumal, T.2
Subramaniam, K.3
-
15
-
-
0029096972
-
Ondansetron clinical pharmacokinetics
-
Roila F, Del Favero A. 1995. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet, 29:95-109.
-
(1995)
Clin Pharmacokinet
, vol.29
, pp. 95-109
-
-
Roila, F.1
Del Favero, A.2
-
16
-
-
0032981475
-
Postoperative nausea and vomiting in paediatric patients
-
Rose JB, Watcha MF. 1999. Postoperative nausea and vomiting in paediatric patients. Br J Anaesth. 83:104-17.
-
(1999)
Br J Anaesth
, vol.83
, pp. 104-117
-
-
Rose, J.B.1
Watcha, M.F.2
-
17
-
-
0036829207
-
Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children
-
Sukhani R, Pappas AL, Lurie JH, et al. 2002. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children. Anesth Analg, 95:1230-5.
-
(2002)
Anesth Analg
, vol.95
, pp. 1230-1235
-
-
Sukhani, R.1
Pappas, A.L.2
Lurie, J.H.3
-
18
-
-
0029926354
-
Risks and benefits of drugs used in the management of postoperative nausea and vomiting
-
Sung YF. 1996. Risks and benefits of drugs used in the management of postoperative nausea and vomiting. Drug Safety, 14:181-97.
-
(1996)
Drug Safety
, vol.14
, pp. 181-197
-
-
Sung, Y.F.1
-
19
-
-
0032958179
-
Antiemetics
-
quiz 166
-
Wadibia EC. 1999. Antiemetics. South Med J, 92:162-5; quiz 166.
-
(1999)
South Med J
, vol.92
, pp. 162-165
-
-
Wadibia, E.C.1
-
20
-
-
0037489355
-
Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery
-
Wagner D, Pandit U, Voepel-Lewis T, et al. 2003. Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery. Paediatr Anaesth, 13:522-6.
-
(2003)
Paediatr Anaesth
, vol.13
, pp. 522-526
-
-
Wagner, D.1
Pandit, U.2
Voepel-Lewis, T.3
|